All Comments by Lon Schneider

  1. Drug Appears Safe in Huntington’s; Experts Split on Functional Benefit
  2. No Pony in There: Bapi Fails Mild to Moderate ApoE4 Carriers
  3. Apomorphine treatment in Alzheimer mice promoting amyloid-β degradation.
  4. Lilly Halts IDENTITY Trials as Patients Worsen on Secretase Inhibitor
  5. Phoenix: Making Trials Work for Patient, Sponsor, Regulator
  6. Serotonergic system genes in psychosis of Alzheimer dementia: meta-analysis.
  7. Effect of short-term exposure to dichlorvos on synaptic plasticity of rat hippocampal slices: involvement of acylpeptide hydrolase and alpha(7) nicotinic receptors.
  8. Tarenflurbil protection from cytotoxicity is associated with an upregulation of neurotrophins.
  9. Effect of a short- and long-term treatment with Ginkgo biloba extract on amyloid precursor protein levels in a transgenic mouse model relevant to Alzheimer's disease.
  10. Alzheimer disease and cognitive reserve: variation of education effect with carbon 11-labeled Pittsburgh Compound B uptake.
  11. Leon Thal Symposium Webinar
  12. Breakthrough or False Hope? Etanercept Case Report Draws Scrutiny
  13. Researchers Conclude: Cholinesterase Inhibitors Don’t Delay Alzheimer’s
  14. Philadelphia: European Trial of Alzhemed Ends, Marketing Morphs to Supplement
  15. FDA Deems U.S. Alzhemed Trial Results Inconclusive